Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study.
Could behavioral therapies target specific deficits in multiple sclerosis patients?
Cognitive reserve and patient-reported outcomes in multiple sclerosis.
The grey matter correlates of impaired decision-making in multiple sclerosis.
JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants.
Multiple sclerosis: Oral BG12 for treatment of relapsing-remitting MS.
How safe could intrathecal transplantation of mesenchymal stem cells be considered in multiple sclerosis?-Reply.
Self-efficacy and health status improve after a wellness program in persons with multiple sclerosis.
A case of post-vaccination optic neuritis: coincidence or causative?
Vitamin D in health and disease: a literature review.
New methods for multiple sclerosis drug discovery.
Bilateral idiopathic optic neuritis in pregnancy.
Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue.
Passive induction of experimental allergic encephalomyelitis.
Acute exacerbation of multiple sclerosis presenting with facial metamorphopsia and palinopsia.
Riluzole.
Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy.
Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes.
HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
Post-infective transverse myelitis following Streptococcus pneumoniae meningitis with radiological features of acute disseminated encephalomyelitis: a case report.
Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis.
[Emerging therapies for multiple sclerosis.]
Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
Consequences of NMO-IgG binding to aquaporin-4 in neuromyelitis optica.
Deficiency of prolyl oligopeptidase in mice disturbs synaptic plasticity and reduces anxiety-like behaviour, body weight, and brain volume.
Pages
« first
‹ previous
…
215
216
217
218
219
220
221
222
223
…
next ›
last »